CONMED CORPORATION Cash and Cash Equivalents, Period Increase (Decrease)
CONMED CORPORATION (CNMD) reported Cash and Cash Equivalents, Period Increase (Decrease) of $8.35 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-24.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2020-02-24
- CONMED CORPORATION cash and cash equivalents, period increase (decrease) for the quarter ending 2019-12-31 was -$4.21M.
- CONMED CORPORATION cash and cash equivalents, period increase (decrease) for the quarter ending 2019-09-30 was $7.52M, a 19.54% increase year-over-year.
- CONMED CORPORATION cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was -$858.00K, a 137.80% decline year-over-year.
- CONMED CORPORATION cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was $5.90M.
- CONMED CORPORATION cash and cash equivalents, period increase (decrease) for fiscal 2019 was $8.35M.
- CONMED CORPORATION cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$15.11M, a 390.93% decline from fiscal 2017.
- CONMED CORPORATION cash and cash equivalents, period increase (decrease) for fiscal 2017 was $5.19M.
- CONMED CORPORATION cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$45.08M, a 830.33% decline from fiscal 2015.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$4.21M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $3.31M derived: sum of 2 quarters · filed 2020-02-24 | $2.45M derived: sum of 3 quarters · filed 2020-02-24 | $8.35M 10-K · filed 2020-02-24 |
| 2019-09-30 | $7.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $6.66M derived: sum of 2 quarters · filed 2019-10-31 | $12.56M 10-Q · filed 2019-10-31 | $377.00K derived: sum of 4 quarters · filed 2020-02-24 |
| 2019-06-30 | -$858.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $5.04M 10-Q · filed 2019-08-01 | -$7.14M derived: sum of 3 quarters · filed 2020-02-24 | -$852.00K derived: sum of 4 quarters · filed 2020-02-24 |
| 2019-03-31 | $5.90M 10-Q · filed 2019-04-26 | -$6.28M derived: sum of 2 quarters · filed 2020-02-24 | $6.00K derived: sum of 3 quarters · filed 2020-02-24 | $2.28M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-12-31 | -$12.18M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | -$5.89M derived: sum of 2 quarters · filed 2020-02-24 | -$3.62M derived: sum of 3 quarters · filed 2020-02-24 | -$15.11M 10-K · filed 2020-02-24 |
| 2018-09-30 | $6.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $8.56M derived: sum of 2 quarters · filed 2019-10-31 | -$2.93M 10-Q · filed 2019-10-31 | -$14.34M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $2.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$9.22M 10-Q · filed 2019-08-01 | -$20.63M derived: sum of 3 quarters · filed 2020-02-24 | -$16.74M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | -$11.49M 10-Q · filed 2019-04-26 | -$22.90M derived: sum of 2 quarters · filed 2020-02-24 | -$19.01M derived: sum of 3 quarters · filed 2020-02-24 | -$13.53M derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | -$11.41M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | -$7.52M derived: sum of 2 quarters · filed 2020-02-24 | -$2.04M derived: sum of 3 quarters · filed 2020-02-24 | $5.19M 10-K · filed 2020-02-24 |
| 2017-09-30 | $3.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $9.37M derived: sum of 2 quarters · filed 2018-11-02 | $16.61M 10-Q · filed 2018-11-02 | $17.09M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $5.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $12.71M 10-Q · filed 2018-08-02 | $13.19M derived: sum of 3 quarters · filed 2019-02-25 | $16.85M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | $7.23M 10-Q · filed 2018-04-26 | $7.71M derived: sum of 2 quarters · filed 2019-02-25 | $11.37M derived: sum of 3 quarters · filed 2019-02-25 | $14.77M derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | $480.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $4.13M derived: sum of 2 quarters · filed 2019-02-25 | $7.53M derived: sum of 3 quarters · filed 2019-02-25 | -$45.08M 10-K · filed 2019-02-25 |
| 2016-09-30 | $3.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $7.05M derived: sum of 2 quarters · filed 2017-11-02 | -$45.56M 10-Q · filed 2017-11-02 | -$38.38M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $3.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | -$49.21M 10-Q · filed 2017-07-27 | -$42.03M derived: sum of 3 quarters · filed 2018-02-26 | -$38.92M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | -$52.61M 10-Q · filed 2017-04-27 | -$45.43M derived: sum of 2 quarters · filed 2018-02-26 | -$42.32M derived: sum of 3 quarters · filed 2018-02-26 | -$45.84M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $7.18M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $10.29M derived: sum of 2 quarters · filed 2018-02-26 | $6.78M derived: sum of 3 quarters · filed 2018-02-26 | $6.17M 10-K · filed 2018-02-26 |
| 2015-09-30 | $3.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | -$403.00K derived: sum of 2 quarters · filed 2016-10-28 | -$1.01M 10-Q · filed 2016-10-28 | $712.00K derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | -$3.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | -$4.12M 10-Q · filed 2016-07-28 | -$2.40M derived: sum of 3 quarters · filed 2017-02-27 | $1.80M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | -$603.00K 10-Q · filed 2016-05-02 | $1.11M derived: sum of 2 quarters · filed 2017-02-27 | $5.32M derived: sum of 3 quarters · filed 2017-02-27 | $9.41M derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-12-31 | $1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $5.92M derived: sum of 2 quarters · filed 2017-02-27 | $10.01M derived: sum of 3 quarters · filed 2017-02-27 | $11.89M 10-K · filed 2017-02-27 |
| 2014-09-30 | $4.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-23 | $8.30M derived: sum of 2 quarters · filed 2015-10-23 | $10.17M 10-Q · filed 2015-10-23 | $14.78M derived: sum of 4 quarters · filed 2016-02-23 |
| 2014-06-30 | $4.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-27 | $5.97M 10-Q · filed 2015-07-27 | $10.58M derived: sum of 3 quarters · filed 2016-02-23 | $22.29M derived: sum of 4 quarters · filed 2016-02-23 |
| 2014-03-31 | $1.88M 10-Q · filed 2015-04-24 | $6.49M derived: sum of 2 quarters · filed 2016-02-23 | $18.20M derived: sum of 3 quarters · filed 2016-02-23 | $23.96M derived: sum of 4 quarters · filed 2016-02-23 |
| 2013-12-31 | $4.61M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $16.32M derived: sum of 2 quarters · filed 2016-02-23 | $22.08M derived: sum of 3 quarters · filed 2016-02-23 | $30.72M 10-K · filed 2016-02-23 |
| 2013-09-30 | $11.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24 | $17.47M derived: sum of 2 quarters · filed 2014-10-24 | $26.11M 10-Q · filed 2014-10-24 | $30.01M derived: sum of 4 quarters · filed 2015-02-23 |
| 2013-06-30 | $5.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-25 | $14.40M 10-Q · filed 2014-07-25 | $18.30M derived: sum of 3 quarters · filed 2015-02-23 | $21.88M derived: sum of 4 quarters · filed 2015-02-23 |
| 2013-03-31 | $8.64M 10-Q · filed 2014-04-25 | $12.54M derived: sum of 2 quarters · filed 2015-02-23 | $16.11M derived: sum of 3 quarters · filed 2015-02-23 | $12.90M derived: sum of 4 quarters · filed 2015-02-23 |
| 2012-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | $7.47M derived: sum of 2 quarters · filed 2015-02-23 | $4.27M derived: sum of 3 quarters · filed 2015-02-23 | -$2.33M 10-K · filed 2015-02-23 |
| 2012-09-30 | $3.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | $365.00K derived: sum of 2 quarters · filed 2013-10-28 | -$6.23M 10-Q · filed 2013-10-28 | -$20.06M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-06-30 | -$3.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-29 | -$9.80M 10-Q · filed 2013-07-29 | -$23.64M derived: sum of 3 quarters · filed 2014-02-24 | -$8.09M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-03-31 | -$6.59M 10-Q · filed 2013-04-29 | -$20.43M derived: sum of 2 quarters · filed 2014-02-24 | -$4.88M derived: sum of 3 quarters · filed 2014-02-24 | $1.51M derived: sum of 4 quarters · filed 2014-02-24 |
| 2011-12-31 | -$13.84M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | $1.72M derived: sum of 2 quarters · filed 2014-02-24 | $8.11M derived: sum of 3 quarters · filed 2014-02-24 | $13.63M 10-K · filed 2014-02-24 |
| 2011-09-30 | $15.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-29 | $21.94M derived: sum of 2 quarters · filed 2012-10-29 | $27.47M 10-Q · filed 2012-10-29 | $23.36M derived: sum of 4 quarters · filed 2013-02-25 |
| 2011-06-30 | $6.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-30 | $11.91M 10-Q · filed 2012-07-30 | $7.81M derived: sum of 3 quarters · filed 2013-02-25 | $15.84M derived: sum of 4 quarters · filed 2013-02-25 |
| 2011-03-31 | $5.52M 10-Q · filed 2012-05-01 | $1.42M derived: sum of 2 quarters · filed 2013-02-25 | $9.45M derived: sum of 3 quarters · filed 2013-02-25 | |
| 2010-12-31 | -$4.11M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-25 | $3.93M derived: sum of 2 quarters · filed 2013-02-25 | $2.32M 10-K · filed 2013-02-25 | |
| 2010-09-30 | $8.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-01 | $6.43M 10-Q · filed 2011-11-01 | ||
| 2010-06-30 | -$1.61M 10-Q · filed 2011-08-09 | |||
| 2009-12-31 | -$1.71M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |